vs

Side-by-side financial comparison of ACME UNITED CORP (ACU) and CODEXIS, INC. (CDXS). Click either name above to swap in a different company.

ACME UNITED CORP is the larger business by last-quarter revenue ($52.3M vs $38.9M, roughly 1.3× CODEXIS, INC.). CODEXIS, INC. runs the higher net margin — 24.7% vs 1.9%, a 22.8% gap on every dollar of revenue. On growth, CODEXIS, INC. posted the faster year-over-year revenue change (81.3% vs 13.8%). Over the past eight quarters, CODEXIS, INC.'s revenue compounded faster (51.0% CAGR vs -2.9%).

Acme United Corporation is a supplier of cutting, measuring and safety products for the school, home, office, hardware and industrial markets. The company was organized as a partnership in 1867 and incorporated in 1873 under the laws of the State of Connecticut. It is publicly traded on the NYSE American with symbol ACU.

Codexis, Inc. is a protein engineering company that develops enzymes for pharmaceutical, food and medical applications.

ACU vs CDXS — Head-to-Head

Bigger by revenue
ACU
ACU
1.3× larger
ACU
$52.3M
$38.9M
CDXS
Growing faster (revenue YoY)
CDXS
CDXS
+67.5% gap
CDXS
81.3%
13.8%
ACU
Higher net margin
CDXS
CDXS
22.8% more per $
CDXS
24.7%
1.9%
ACU
Faster 2-yr revenue CAGR
CDXS
CDXS
Annualised
CDXS
51.0%
-2.9%
ACU

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
ACU
ACU
CDXS
CDXS
Revenue
$52.3M
$38.9M
Net Profit
$985.0K
$9.6M
Gross Margin
39.7%
94.8%
Operating Margin
3.3%
27.1%
Net Margin
1.9%
24.7%
Revenue YoY
13.8%
81.3%
Net Profit YoY
-40.4%
192.5%
EPS (diluted)
$0.24
$0.13

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ACU
ACU
CDXS
CDXS
Q1 26
$52.3M
Q4 25
$47.5M
$38.9M
Q3 25
$49.1M
$8.6M
Q2 25
$54.0M
$15.3M
Q1 25
$46.0M
$7.5M
Q4 24
$45.9M
$21.5M
Q3 24
$48.2M
$12.8M
Q2 24
$55.4M
$8.0M
Net Profit
ACU
ACU
CDXS
CDXS
Q1 26
$985.0K
Q4 25
$1.9M
$9.6M
Q3 25
$1.9M
$-19.6M
Q2 25
$4.8M
$-13.3M
Q1 25
$1.7M
$-20.7M
Q4 24
$1.7M
$-10.4M
Q3 24
$2.2M
$-20.6M
Q2 24
$4.5M
$-22.8M
Gross Margin
ACU
ACU
CDXS
CDXS
Q1 26
39.7%
Q4 25
38.2%
94.8%
Q3 25
39.1%
71.3%
Q2 25
41.0%
86.3%
Q1 25
39.0%
63.8%
Q4 24
38.7%
83.0%
Q3 24
38.5%
66.4%
Q2 24
40.8%
56.6%
Operating Margin
ACU
ACU
CDXS
CDXS
Q1 26
3.3%
Q4 25
6.1%
27.1%
Q3 25
6.1%
-220.3%
Q2 25
11.8%
-83.9%
Q1 25
5.3%
-271.6%
Q4 24
5.0%
-34.2%
Q3 24
6.1%
-129.0%
Q2 24
11.5%
-284.9%
Net Margin
ACU
ACU
CDXS
CDXS
Q1 26
1.9%
Q4 25
3.9%
24.7%
Q3 25
3.9%
-228.1%
Q2 25
8.8%
-86.6%
Q1 25
3.6%
-274.3%
Q4 24
3.7%
-48.4%
Q3 24
4.6%
-160.8%
Q2 24
8.0%
-285.2%
EPS (diluted)
ACU
ACU
CDXS
CDXS
Q1 26
$0.24
Q4 25
$0.46
$0.13
Q3 25
$0.46
$-0.22
Q2 25
$1.16
$-0.16
Q1 25
$0.41
$-0.25
Q4 24
$0.43
$-0.12
Q3 24
$0.54
$-0.29
Q2 24
$1.09
$-0.32

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ACU
ACU
CDXS
CDXS
Cash + ST InvestmentsLiquidity on hand
$4.2M
$78.2M
Total DebtLower is stronger
$33.0M
$40.1M
Stockholders' EquityBook value
$116.7M
$50.5M
Total Assets
$195.2M
$147.8M
Debt / EquityLower = less leverage
0.28×
0.79×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ACU
ACU
CDXS
CDXS
Q1 26
$4.2M
Q4 25
$3.6M
$78.2M
Q3 25
$5.1M
$58.7M
Q2 25
$3.6M
$66.3M
Q1 25
$3.4M
$59.8M
Q4 24
$6.4M
$73.5M
Q3 24
$5.7M
$90.3M
Q2 24
$3.8M
$73.2M
Total Debt
ACU
ACU
CDXS
CDXS
Q1 26
$33.0M
Q4 25
$40.1M
Q3 25
$39.7M
Q2 25
$39.4M
Q1 25
$29.2M
Q4 24
$28.9M
Q3 24
$28.6M
Q2 24
$28.4M
Stockholders' Equity
ACU
ACU
CDXS
CDXS
Q1 26
$116.7M
Q4 25
$117.6M
$50.5M
Q3 25
$115.8M
$38.5M
Q2 25
$113.7M
$55.6M
Q1 25
$108.3M
$49.6M
Q4 24
$107.0M
$66.9M
Q3 24
$106.3M
$73.4M
Q2 24
$104.0M
$61.4M
Total Assets
ACU
ACU
CDXS
CDXS
Q1 26
$195.2M
Q4 25
$171.0M
$147.8M
Q3 25
$173.0M
$124.0M
Q2 25
$170.9M
$138.2M
Q1 25
$163.0M
$128.9M
Q4 24
$162.2M
$149.0M
Q3 24
$165.5M
$148.2M
Q2 24
$173.5M
$132.0M
Debt / Equity
ACU
ACU
CDXS
CDXS
Q1 26
0.28×
Q4 25
0.79×
Q3 25
1.03×
Q2 25
0.71×
Q1 25
0.59×
Q4 24
0.43×
Q3 24
0.39×
Q2 24
0.46×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ACU
ACU
CDXS
CDXS
Operating Cash FlowLast quarter
$20.1M
Free Cash FlowOCF − Capex
$19.6M
FCF MarginFCF / Revenue
50.3%
Capex IntensityCapex / Revenue
1.3%
Cash ConversionOCF / Net Profit
2.09×
TTM Free Cash FlowTrailing 4 quarters
$-23.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ACU
ACU
CDXS
CDXS
Q1 26
Q4 25
$8.2M
$20.1M
Q3 25
$7.1M
$-7.7M
Q2 25
$6.3M
$-18.0M
Q1 25
$-3.3M
$-13.8M
Q4 24
$6.4M
$-16.5M
Q3 24
$8.9M
$-13.0M
Q2 24
$6.9M
$-12.2M
Free Cash Flow
ACU
ACU
CDXS
CDXS
Q1 26
Q4 25
$7.3M
$19.6M
Q3 25
$301.0K
$-7.9M
Q2 25
$4.7M
$-20.5M
Q1 25
$-4.7M
$-15.1M
Q4 24
$4.7M
$-18.2M
Q3 24
$7.5M
$-14.0M
Q2 24
$4.4M
$-12.6M
FCF Margin
ACU
ACU
CDXS
CDXS
Q1 26
Q4 25
15.3%
50.3%
Q3 25
0.6%
-91.7%
Q2 25
8.7%
-133.6%
Q1 25
-10.2%
-199.6%
Q4 24
10.2%
-85.0%
Q3 24
15.6%
-109.0%
Q2 24
8.0%
-157.5%
Capex Intensity
ACU
ACU
CDXS
CDXS
Q1 26
Q4 25
1.9%
1.3%
Q3 25
13.8%
2.1%
Q2 25
3.0%
16.4%
Q1 25
2.9%
16.7%
Q4 24
3.7%
8.3%
Q3 24
2.8%
7.8%
Q2 24
4.5%
5.0%
Cash Conversion
ACU
ACU
CDXS
CDXS
Q1 26
Q4 25
4.34×
2.09×
Q3 25
3.72×
Q2 25
1.33×
Q1 25
-2.02×
Q4 24
3.73×
Q3 24
3.99×
Q2 24
1.55×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons